Evidence map›Paper›PMID 27421765›Full record

SynthesisContraception2016

The safety of intrauterine devices in breastfeeding women: a systematic review.

Erin N Berry-Bibee, Naomi K Tepper, Tara C Jatlaoui, Maura K Whiteman, Denise J Jamieson, Kathryn M Curtis

Abstract readSystematic Review
In one paragraph

Synthesis in Contraception, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Barriers to post-placental intrauterine device receipt among expectant minority women.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2021
    Article
  10. Article
  11. Postpartum intrauterine device placement: a patient-friendly option.Contraception and reproductive medicine · 2018
    Review
  12. Long-Acting Reversible Contraception.The New England journal of medicine · 2017
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Erin N Berry-BibeeDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: wnw4@cdc.gov.
Naomi K TepperDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Tara C JatlaouiDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Maura K WhitemanDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Denise J JamiesonDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kathryn M CurtisDivision of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectivesTo investigate levonorgestrel (LNG)-releasing and copper-bearing (Cu) intrauterine device (IUD) safety among breastfeeding women and, for Cu-IUD use, breastfeeding performance and infant health. STUDY

designSystematic review.

methodsWe searched PubMed, Embase, Cochrane Library and clinicaltrials.gov for articles through January 2016. We included studies of Cu-IUD or LNG-IUD users comparing IUD-specific (perforation, expulsion) and other contraceptive-related (infection, removal/cessation due to bleeding/pain and other adverse events) outcomes for breastfeeding vs. non-breastfeeding women. We also included studies of breastfeeding women comparing contraceptive-related outcome for IUD-users vs. other contraceptive-method users. Finally, we included studies comparing breastfeeding outcomes among Cu-IUD users to users of other nonhormonal contraceptives or no contraception.

resultsOf 548 articles identified, 23 (16 studies) met the inclusion criteria. Two studies suggested that the risk of IUD perforation was 6-10 times higher among breastfeeding vs. non-breastfeeding women. Seven studies suggested that risks for other adverse events were similar or lower among breastfeeding vs. non-breastfeeding women. Three studies among breastfeeding women found no increased risk of adverse events in IUD users vs. nonusers. Breastfeeding performance and infant growth were similar for Cu-IUD users and users of other nonhormonal methods or no contraception.

conclusionOverall, risks for adverse events among IUD users, including expulsion, pain and removals, were similar or lower for breastfeeding women vs. non-breastfeeding women. Uterine perforation with IUDs, while rare, appeared more frequent among breastfeeding women. No evidence indicated that Cu-IUD use in breastfeeding women influences breastfeeding performance or infant growth.

Indexed as

Breast FeedingContraceptionContraceptive Agents, FemaleEquipment SafetyFemaleHumansIntrauterine Devices, CopperLevonorgestrelPostpartum PeriodRandomized Controlled Trials as TopicRisk AssessmentUterine PerforationContraceptive Agents, FemaleLevonorgestrelbreastfeedingIntrauterine deviceIUDuterine perforation

Identifiers

PMID27421765
PMCPMC11283814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.